May 5, 2015
SEATTLE -- The Cancer Immunotherapy Trials Network (CITN) and NanoString Technologies, Inc.(Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced a multi-year translational research collaboration to discover biomarkers that predict clinical outcomes for cancer immunotherapies, both as single agents and in combination. The collaboration will involve the systematic [...]
Keith M. Gehl Elected to Kewaunee Scientific Board of Directors
May 5, 2015
STATESVILLE, N.C.-- Kewaunee Scientific Corporation KEQU, -2.68% announced today the election of Keith M. Gehl to Kewaunee Scientific's Board of Directors, effective April 29, 2015. Mr. Gehl is a resident of Concord, North Carolina. The election of Mr. Gehl is in conjunction with Ross W. McCanless' notification to the Board of his intention to resign [...]
Medidata Unveils Open-Source Connector Linking Apple® ResearchKit™ to the Medidata Clinical Cloud®
May 5, 2015
NEW YORK, N.Y. -- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of an open-source connector linking Apple® ResearchKit™ with the Medidata Clinical Cloud® platform. This mechanism will enable life sciences companies and academic institutions to map data generated by ResearchKit apps into [...]
May 5, 2015
Delft -- DELMIC develops and manufactures products which are focused on high performance, user friendly, integrated microscopy solutions. Users of Delmic's SPARC technology from Stanford University and the FOM Institute AMOLF in the Netherlands are using cathodoluminescence measurements for nanoscale optical tomography. Engineers at Stanford University and the FOM Institute AMOLF, in the Netherlands, have [...]
May 5, 2015
STEMCELL Technologies Inc. has today announced that it has signed a license agreement with the Salk Institute for Biological Sciences for the rights to commercialize BrainPhys™ Neuronal Medium. BrainPhys™ medium, described in a recent publication in the Proceedings of the National Academy of Sciences (C. Bardy et al., Epub ahead of print), was invented by [...]
MyDx, Inc. Announces Completion of Reverse Merger
May 5, 2015
SAN DIEGO, CA -- MyDx, Inc., Nevada corporation (PINKSHEETS: MYDX) (the "Company"), has completed a reverse merger on May 5, 2015 pursuant to which CDx, Inc., a Delaware corporation, became a wholly owned subsidiary of the Company. The Company trades on the OTC Markets under the symbol "MYDX". The Company intends to "up-list" to the [...]
Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances
May 4, 2015
Boston, MA -- Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced the release of Genedata Biologics 5.0, the latest version of its enterprise solution for biologics R&D. This first-in-class workflow platform for biopharma R&D enables more efficient discovery and development of novel biotherapeutics. Version 5.0 enables [...]
Phenomenex Creates Comprehensive Sample Preparation Guide for Improved Chromatographic Analysis
May 4, 2015
Torrance, CA -– Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the publication of a new sample preparation guide and selection tool to help scientists produce cleaner samples for more efficient chromatographic analysis. The use of sample preparation has been on the increase in recent [...]
MKS INSTRUMENTS ANNOUNCES INCREASED QUARTERLY CASH DIVIDEND
May 4, 2015
ANDOVER, Mass. -- MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its board of directors has authorized a quarterly cash dividend of $0.17 per share, an increase since its most recent dividend of $0.165 per share, payable on June 12, 2015 to shareholders of [...]
QIAGEN partners with world’s largest sequencing provider
May 4, 2015
Shenzhen, China, and Redwood City, California -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that it has expanded its relationship with BGI, the world’s largest genomics organization, to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing [...]
